• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性呼吸窘迫综合征

Acute respiratory distress syndrome.

作者信息

Powers Kristen

机构信息

Kristen Powers practices in pulmonary critical care at Carolinas Medical Center in Charlotte, N.C. The author has disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2022 Apr 1;35(4):29-33. doi: 10.1097/01.JAA.0000823164.50706.27.

DOI:10.1097/01.JAA.0000823164.50706.27
PMID:35276715
Abstract

Acute respiratory distress syndrome (ARDS) is a severe, often fatal, lung condition frequently seen in patients in the ICU. ARDS is triggered by an inciting event such as pneumonia or sepsis, which is followed by an inappropriate host inflammatory response that results in pulmonary edema and impaired gas exchange, and may progress to fibrosis. With the increased spotlight and discussion focused on ARDS during the COVID-19 pandemic, healthcare providers must be able to identify and manage symptoms based on evidence-based research.

摘要

急性呼吸窘迫综合征(ARDS)是一种严重的、通常致命的肺部疾病,在重症监护病房(ICU)的患者中很常见。ARDS由诸如肺炎或败血症等诱发事件引发,随后是不适当的宿主炎症反应,导致肺水肿和气体交换受损,并可能进展为纤维化。随着在2019冠状病毒病大流行期间对ARDS的关注度和讨论增加,医疗保健提供者必须能够根据循证研究来识别和管理症状。

相似文献

1
Acute respiratory distress syndrome.急性呼吸窘迫综合征
JAAPA. 2022 Apr 1;35(4):29-33. doi: 10.1097/01.JAA.0000823164.50706.27.
2
Acute Respiratory Distress Syndrome: Diagnosis and Management.急性呼吸窘迫综合征:诊断与管理。
Am Fam Physician. 2020 Jun 15;101(12):730-738.
3
Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.2020年2月钻石公主号邮轮上两名乘客的新型冠状病毒肺炎与急性呼吸窘迫综合征临床病程比较
Am J Case Rep. 2020 Aug 19;21:e926835. doi: 10.12659/AJCR.926835.
4
Could reperfusion pulmonary oedema explain worsening progress in COVID-19 pneumonia?再灌注性肺水肿能解释新冠病毒肺炎病情的恶化进展吗?
Emerg Med J. 2020 Nov;37(11):705-706. doi: 10.1136/emermed-2020-210085. Epub 2020 Sep 28.
5
[Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].2019冠状病毒病所致急性呼吸窘迫综合征的治疗不同于传统急性呼吸窘迫综合征
Zhonghua Shao Shang Za Zhi. 2020 May 20;36(5):330-333. doi: 10.3760/cma.j.cn501120-20200407-00214.
6
Two fatal cases of hidden pneumonia in young people.两例年轻人隐匿性肺炎致死病例。
J Forensic Sci. 2010 Sep;55(5):1380-3. doi: 10.1111/j.1556-4029.2010.01413.x.
7
Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.急性呼吸窘迫综合征:治疗 COVID-19 进展的潜在治疗干预措施对治疗其他疾病进展的有效性-系统评价。
BMJ Open Respir Res. 2023 Sep;10(1). doi: 10.1136/bmjresp-2022-001525.
8
Lung ultrasound score assessing the pulmonary edema in pediatric acute respiratory distress syndrome received continuous hemofiltration therapy: a prospective observational study.肺超声评分评估接受连续血液滤过治疗的小儿急性呼吸窘迫综合征的肺水肿:一项前瞻性观察研究。
BMC Pulm Med. 2021 Jan 25;21(1):40. doi: 10.1186/s12890-021-01394-w.
9
Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 相关急性呼吸窘迫综合征的流量控制通气:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 11;21(1):781. doi: 10.1186/s13063-020-04708-1.
10
Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.镰状细胞病成人患者合并急性呼吸窘迫综合征的严重 COVID-19:病例报告。
BMC Pulm Med. 2021 Jan 29;21(1):46. doi: 10.1186/s12890-021-01412-x.

引用本文的文献

1
Study on the clinical characteristics, treatment, and outcome influencing factors of severe pneumonia complicated with ARDS.严重肺炎合并 ARDS 的临床特征、治疗及预后影响因素研究。
Medicine (Baltimore). 2024 Nov 8;103(45):e40316. doi: 10.1097/MD.0000000000040316.
2
Clinical significance and potential mechanism of hsa_circ_0006892 in acute respiratory distress syndrome complicated with pulmonary fibrosis.hsa_circ_0006892 在急性呼吸窘迫综合征合并肺纤维化中的临床意义及潜在机制。
Mol Biol Rep. 2024 Nov 4;51(1):1120. doi: 10.1007/s11033-024-10047-0.
3
QbD driven targeted pulmonary delivery of dexamethasone-loaded chitosan microspheres: Biodistribution and pharmacokinetic study.
质量源于设计驱动的载地塞米松壳聚糖微球的靶向肺部给药:生物分布和药代动力学研究。
Saudi Pharm J. 2023 Sep;31(9):101711. doi: 10.1016/j.jsps.2023.101711. Epub 2023 Jul 26.
4
Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells.从人多能干细胞衍生类器官中模拟纤维化相关的呼吸疾病。
Int J Mol Sci. 2023 Feb 23;24(5):4413. doi: 10.3390/ijms24054413.